Deal-Update Venture Capital / M&A (01/2025 )

Tobias Brickwedde

Lars Henrik Dieball

Dr. Marco Eickmann

Constanze Hachmann

Frank Hahn

Philipp Hoene

Dr. Lorenz Jellinghaus

Roman W. Krug

Jan-Phillip Kunz

Dr. Bernhard Noreisch

Philipp Schmitter

Dr. Sebastian Sumalvico

Björn Weidehaas

Deal-Update: There's a lot going on in our Venture Capital / M&A-Team. That's why we will post quarterly deal-updates from now on. Here is the first one 🚀 Congratulation to all our clients and other parties involved.

29.04.2025 | Venture Capital / M&A

LUTZ | ABEL professionals advised …

  • NEURA Robotics GmbH on EUR 120 M Series B Financing Round
  • Graphit Lifestyle on Participation in IONIQ skincare
  • AlphaPet Ventures on Equity Financing
  • Bayern Kapital in Series A Financing Round of ubiMaster
  • NRW.BANK on Investment in DISCO Pharmaceuticals GmbH
  • HTGF on Exit Transaction GQ Bio Therapeutics to Pacira BioSciences
  • AMSilk GmbH on extension of Series C Financing Round
  • MIG 17 on Series B Financing Round of CoreMedic GmbH
  • Samsung Catalyst Fund on Financing Round of Solaris SE
  • BonVenture on EUR 15m Series B Financing Round of node.energy GmbH
  • BayBG and Bayern Kapital on Series A3 Financing Round of AlfaDocs GmbH
  • ScaleUp-Fonds Bayern on Financing Round of tado°
  • MIG and Bayern Kapital on Financing Round of German Bionic Systems GmbH
  • DIGIT4U Group on Acquisition of Helmich IT-Security GmbH
  • Soleal Unternehmerkapital AG on the acquisition of furniture factory Martin Staud
  • caesar. on Financing Round of Optimeleon
  • JUNE on Financing Round with 5i Ventures
  • Cityscaper GmbH on Series Seed
  • Cell2Green GmbH on Series Seed
  • Bayern Kapital on 113 Mio Series B Follow on in Marvel Fusion
  • Bayern Kapital on 25 Mio Series B in OroraTech
  • Bayern Kapital on Series Seed in hema.to
  • Bayern Kapital on Series Seed in Munich Quantum Instruments
  • Founders of Vispato GmbH on the sale of their company to HR WORKS